No Data
Fanpeb announced the Financial Estimates for the fiscal year ending December 2024, expecting business revenue of 0.006 billion yen.
FanPep <4881> announced its financial estimates for the fiscal year ending December 2024 (from January 1, 2024 to December 31, 2024) on the 6th. Consolidated performance forecasts include business revenue of 0.006 billion yen (compared to 0 billion yen in the previous period), an operating loss of 0.845 billion yen (compared to 0.994 billion yen in the previous period), an ordinary loss of 0.833 billion yen (compared to 0.94 billion yen in the previous period), and a net loss attributable to shareholders of the parent company of 0.826 billion yen (compared to 0.933 billion yen in the previous period). Business revenue is expected to come from sales of functional peptides for the cosmetics sector, among others.
<Today's individual materials> WOLVES, Canvas, Right-On, Dai-seki, ETC (Announced on the 6th)
▽WOLVES <194A.T> has resolved to acquire the operations of Yasuda Animal Hospital (Nishinomiya City, Hyogo Prefecture) and signed a business transfer agreement. ▽Canvas <4575.T> has received a patent grant from the U.S. Patent Office for the immunotherapy candidate compound "CBT005". ▽Right-On <7445.T> reported that same-store sales in December decreased by 15.4% compared to the same month last year, marking the tenth consecutive month below the previous year. ▽Daiseki S <1712.T> has reported the cumulative results for the third quarter of the period ending February 25 (March-November 24).
Dai Seki, 3Q operating profit decreased by 6.8% to 11.1 billion yen.
The consolidated performance for the third quarter of the fiscal year ending February 2025, announced by Dai Seki <9793>, showed a revenue of 50.032 billion yen, a decrease of 6.6% year-on-year, and an operating profit of 11.127 billion yen, down 6.8% compared to the same period last year. The soil contamination treatment related business of Dai Seki Environmental Solutions <1712> experienced significant declines in revenue and profit due to the conclusion of a large-scale soil treatment project ordered in the previous year; however, the progress rate is generally on track as high-value projects, such as large-scale factory waste removal consulting, are being resumed.
Key points of interest for PTS on the 6th = Fujitsu, Bike King, Asteria, Next Stage ETC.
▽Fujitsu <6755.T>, TOB (Stock Public Purchase) by Paloma Reem Holdings. The purchase price is 2808 yen. ▽Bike King <3377.T>, raised the consolidated operating profit Financial Estimates for the fiscal year ending November 2024 from 120 million yen to 290 million yen (previous period had a loss of 170 million yen). The auction market has remained more stable than expected. ▽Asteria <3853.T>, increased the consolidated operating profit Financial Estimates for the fiscal year ending March 2025 to a profit of 600 million yen (the previous period had a loss of 3.64 billion yen, previous estimates).
FunPep: Notice regarding publication of earnings forecasts
FunPep Sees FY Parent Pretax Loss Y796.00M